LivingGLP1
Study S002471

Transform CV Risk in Diabetes

Registration

Registration
NCT05948969
Acronym
CVRiD
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
UNKNOWN
Enrollment
750
Start
2023-09-01
Primary completion
2024-07-01
Lead sponsor
American College of Cardiology
Conditions
Type 2 Diabetes
Interventions
OTHER:Decision support; OTHER:Facilitated referral to a cardiometabolic team-based center
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • New prescription of a SGLT2i and/or GLP-1RA [9 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.